The ArcView Group helped Denver marijuana startups raise more than $1 million, according to a story in
The Economist.
Excerpt:
EVERY stoner has been there. You are sprawled on the couch, smoking trees of the finest Super Lemon Haze, when the phone rings: a friend needs picking up from the station. Happily, help is on the way: pop a Buzzkill, one of several products in development by the masterminds at Hudson Nutraceuticals, and the metabolising of tetrahydrocannabinol in your liver is accelerated, helping you sober up.
Such is the claim of Mike Schreibman, a former NBC executive who co-founded Hudson last summer. He understood he was on to something, he says, when he ate too much cannabis-infused chocolate sauce one day and realised he would do anything to stop the room from spinning.
Mr Schreibman was one of many entrepreneurs peddling their wares this week at a cannabis jamboree in Denver organised by ArcView, an angel-investment group. Together they raised over $1m. But bar the large pot plants on the stage, in many respects the meeting was no different from other gatherings of American investors and businessfolk. Ties, women and non-white faces were scarce. Pitches were peppered with jargon and cheerfully optimistic revenue projections, though not always a clear indication of the product or service on offer. But there was also a strong atmosphere of camaraderie, a sense that here there was an industry to be built rather than turf wars to be fought.
Read the rest
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.